Afatinib down-regulates MCL-1 expression through the PERK-eIF2α-ATF4 axis and leads to apoptosis in head and neck squamous cell carcinoma
about
Modulation of Navitoclax Sensitivity by Dihydroartemisinin-Mediated MCL-1 Repression in BCR-ABL+ B-Lineage Acute Lymphoblastic Leukemia.Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines.Interferon γ suppresses dentin sialophosphoprotein in oral squamous cell carcinoma cells resulting in antitumor effects, via modulation of the endoplasmic reticulum responseAppropriate Sequence for Afatinib and Cisplatin Combination Improves Anticancer Activity in Head and Neck Squamous Cell Carcinoma
P2860
Afatinib down-regulates MCL-1 expression through the PERK-eIF2α-ATF4 axis and leads to apoptosis in head and neck squamous cell carcinoma
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Afatinib down-regulates MCL-1 ...... d neck squamous cell carcinoma
@en
type
label
Afatinib down-regulates MCL-1 ...... d neck squamous cell carcinoma
@en
prefLabel
Afatinib down-regulates MCL-1 ...... d neck squamous cell carcinoma
@en
P2093
P2860
P1476
Afatinib down-regulates MCL-1 ...... d neck squamous cell carcinoma
@en
P2093
Jidong Zou
Jinhua Wang
Peihang Jing
Xianfang Liu
Xiuxiu Liu
Zhenghua Lv
P2860
P304
P577
2016-08-01T00:00:00Z